Spots Global Cancer Trial Database for severe aplastic anemia
Every month we try and update this database with for severe aplastic anemia cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Basiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent Graft-Versus_Host Disease (GVHD) After Nonmyeloablative Allotransplantation for the Treatment of Blood Cancer | NCT00975975 | Acute Myelogeno... Acute Lymphocyt... Chronic Myeloge... Chronic Lymphoc... Myelodysplasia Non-Hodgkin's L... Hodgkin's Disea... Multiple Myelom... Myelofibrosis Anemia, Aplasti... Hemoglobinuria,... | Basiliximab | 18 Years - | Indiana University | |
| Stem Cell Transplant Using Peripheral and Cord Blood Stem Cells to Treat Severe Aplastic Anemia and Myelodysplastic Syndrome | NCT00604201 | Myelodysplastic... Severe Aplastic... | Umbilical Cord ... | 4 Years - 75 Years | National Institutes of Health Clinical Center (CC) | |
| Unrelated Donor Stem Cell Transplantation | NCT01364363 | Severe Aplastic... Paroxysmal Noct... Acute Myelogeno... Acute Lymphobla... Myelodysplastic... Myeloproliferat... Chronic Myeloge... Hodgkin's Lymph... Non-Hodgkin's L... Multiple Myelom... Chronic Lymphoc... Small Lymphocyt... Large Granulocy... | Allogeneic tran... | 18 Years - 69 Years | Scripps Health | |
| Unrelated Umbilical Cord Blood Transplantation Augmented With ALDHbr Umbilical Cord Blood Cells | NCT00692926 | MDS Anemia, Aplasti... Inborn Errors o... Congenital Marr... Congenital Immu... | ALDHbr Umbilica... | - 55 Years | Duke University | |
| Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome | NCT03173937 | Severe Aplastic... Hypo-Plastic MD... Myelodysplastic... | Omidubicel (for... Miltenyi CliniM... | 4 Years - 75 Years | National Institutes of Health Clinical Center (CC) | |
| Phase II Study Evaluating Busulfan and Fludarabine as Preparative Therapy in Adults With Hematopoietic Disorders Undergoing MUD SCT | NCT00516152 | Chronic Myeloid... Acute Myelogeno... Myelodysplasia Acute Lymphocyt... Severe Aplastic... Non-Hodgkin's L... Lymphoprolifera... Multiple Myelom... Advanced Myelop... | Busulfan/Fludar... | 15 Years - 61 Years | University of California, San Francisco | |
| Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant | NCT03192397 | Acute Myeloid L... Adult Acute Lym... Chronic Myeloge... Chronic Myelomo... Graft Versus Ho... Hodgkin Lymphom... Minimal Residua... Myelodysplastic... Myeloproliferat... Non-Hodgkin Lym... Plasma Cell Mye... Severe Aplastic... Waldenstrom Mac... | Allogeneic Hema... Cyclophosphamid... Fludarabine Pho... Laboratory Biom... Melphalan Hydro... Mycophenolate M... Sirolimus Total-Body Irra... | 18 Years - | Roswell Park Cancer Institute | |
| Basiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent Graft-Versus_Host Disease (GVHD) After Nonmyeloablative Allotransplantation for the Treatment of Blood Cancer | NCT00975975 | Acute Myelogeno... Acute Lymphocyt... Chronic Myeloge... Chronic Lymphoc... Myelodysplasia Non-Hodgkin's L... Hodgkin's Disea... Multiple Myelom... Myelofibrosis Anemia, Aplasti... Hemoglobinuria,... | Basiliximab | 18 Years - | Indiana University | |
| Stem Cell Transplant Using Peripheral and Cord Blood Stem Cells to Treat Severe Aplastic Anemia and Myelodysplastic Syndrome | NCT00604201 | Myelodysplastic... Severe Aplastic... | Umbilical Cord ... | 4 Years - 75 Years | National Institutes of Health Clinical Center (CC) | |
| AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion | NCT04099966 | Acute Leukemia Severe Aplastic... Non-hodgkin Lym... Hodgkin Lymphom... Kostmann Diamond Blackfa... Amegakaryocytic... Sickle Cell Dis... Beta-Thalassemi... | alpha beta depl... | 1 Day - 30 Years | New York Medical College | |
| Expanded Access to T-cell Depleted Haplo-Identical Stem Cells for Patients Receiving Haplo-Identical and Unrelated Cord Blood Transplants | NCT01881334 | Hematologic Mal... Inborn Errors o... Immune Deficien... | CliniMACS CD34 ... | - 65 Years | Duke University | |
| Post Transplant Cyclophosphamide (Cytoxan) for GvHD Prophylaxis | NCT02065154 | Leukemia Lymphoma Myelodysplastic... Myelofibrosis Severe Aplastic... Allogeneic Tran... | Cyclophosphamid... | 19 Years - 65 Years | University of Alabama at Birmingham | |
| Post Transplant Cyclophosphamide (Cytoxan) for GvHD Prophylaxis | NCT02065154 | Leukemia Lymphoma Myelodysplastic... Myelofibrosis Severe Aplastic... Allogeneic Tran... | Cyclophosphamid... | 19 Years - 65 Years | University of Alabama at Birmingham | |
| CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant | NCT02061800 | Chronic Myeloid... Acute Myelogeno... Myelodysplastic... Juvenile Myelom... Acute Lymphobla... Lymphoma (Hodgk... | CliniMACS CD34+... Thiotepa Cyclophosphamid... Alemtuzumab Tacrolimus Melphalan Busulfan Fludarabine Methylprednisol... | - 22 Years | Columbia University | |
| Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation of Patients With Hematological Diseases | NCT00056966 | Hematologic Mal... | ANTI-CD45 CAMPATH-1H FK506 Fludarabine Total Body Irra... Stem cell infus... | - | Baylor College of Medicine | |
| Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation of Patients With Hematological Diseases | NCT00056966 | Hematologic Mal... | ANTI-CD45 CAMPATH-1H FK506 Fludarabine Total Body Irra... Stem cell infus... | - | Baylor College of Medicine | |
| Unrelated Donor Stem Cell Transplantation | NCT01364363 | Severe Aplastic... Paroxysmal Noct... Acute Myelogeno... Acute Lymphobla... Myelodysplastic... Myeloproliferat... Chronic Myeloge... Hodgkin's Lymph... Non-Hodgkin's L... Multiple Myelom... Chronic Lymphoc... Small Lymphocyt... Large Granulocy... | Allogeneic tran... | 18 Years - 69 Years | Scripps Health | |
| New York Blood Center National Cord Blood Program | NCT00212407 | Leukemia Lymphoma Genetic Disease Severe Aplastic... Myelodysplasia | Umbilical Cord ... | - | New York Blood Center | |
| Stem Cell Transplant Using Peripheral and Cord Blood Stem Cells to Treat Severe Aplastic Anemia and Myelodysplastic Syndrome | NCT00604201 | Myelodysplastic... Severe Aplastic... | Umbilical Cord ... | 4 Years - 75 Years | National Institutes of Health Clinical Center (CC) | |
| Unrelated Umbilical Cord Blood (UBC)Transplantation | NCT01768845 | Chronic Myeloge... Acute Myelogeno... Myelodysplastic... Multiple Myelom... Hodgkin Lymphom... Non-Hodgkin Lym... Chronic Lymphoc... Acute Lymphocyt... Severe Aplastic... | umbilical cord ... | 16 Years - 70 Years | West Virginia University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
